More adverse events of grade 3 or higher reported for participants receiving pembrolizumab-belzutifan than pembrolizumab-placebo ...

In this study, the researchers examined the risk of multiple primary cancers in male WTC first responders in comparison to the general population.

In the phase 3 SUBITO trial, researchers aimed to compare outcomes with intensified alkylating chemotherapy to those with an HRD-targeting regimen.

Investigators in this retrospective cohort study sought to determine long-term outcomes for patients with platinum-sensitive recurrent ovarian cancer who have exceptional response to PARP inhibitors.

Using individual patient data from phase 2 and 3 trials, investigators analyzed the value of pathologic complete response vs ctDNA clearance after neoadjuvant immunotherapy or perioperative ...

Adding venetoclax to hypomethylating agents increased composite remission but did not improve overall survival in HR-MDS.

Researchers studied the relationship between dermatologist density and the proportion of late-stage melanoma diagnoses.

Investigators compared trial demographics against baseline electronic health record data at 3 NCI–designated cancer centers to identify enrollment gaps.

ASCO's 2026 annual conference in Chicago featured cutting-edge research on treatment strategies for sarcomas such as GIST and ...

Each additional hour per day of prolonged sedentary behavior is associated with a higher hazard of cancer death ...

Investigators in this cohort study sought to determine whether statewide benchmark programs helped to reduce growth in per capita medical expenses.

This study evaluated the demographic and clinicopathologic characteristics of early-onset breast cancer among young Black women to determine the prevalence of hereditary breast cancer germline ...